keyboard_arrow_up

Global Hormone Replacement Therapy Market Research Report 2014-2018

According to the Report “Global Hormone Replacement Therapy Market 2014-2018”, Hormone replacement therapy, also known as hormone therapy, is a means of replacing hormones that are no longer being produced by the body. This type of therapy is usually initiated at menopause or may be started while a woman is in the perimenopausal phase, nearing menopause. Hormone replacement therapy replenishes the hormones required by the human body to function by using bio-identical hormones. The therapy contains estrogen and progesterone, and in some cases testosterone, to reduce symptoms of menopause. This replacement therapy may also protect against osteoporosis, reduce the risk of coronary heart disease, and may prevent or delay the onset of Alzheimer’s disease. Replacement therapy can also increase the chance of developing more serious health complications such as blood clots, breast cancer, uterine cancer, and bowel cancer.

Analysts forecast the Global Hormone Replacement Therapy market will grow at a CAGR of 2.51 percent over the period 2013-2018.

Purchase a Copy of the Report Directly @ http://bit.ly/1jHtEHy.

The Report recognizes the following companies as the key players in the Global Hormone Replacement Therapy Market: Actavis plc, Bayer AG , Merck & Co. Inc., Novartis AG , Novo Nordisk A/S , Abbott Laboratories Ltd., Amgen Inc., ANI Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., MylanLaboratories Inc., Orion Corp., QuatRx Pharmaceuticals Co., Teva Pharmaceutical Industries Ltd., TherapeuticsMD Inc.

The Global Hormone Replacement Therapy market is experiencing increased interest in non-hormonal therapies. This trend shift toward non-hormonal therapies for menopausal symptoms and osteoporosis has been apparent since the Women’s Health Initiative Study in 2002. In 2013, the US FDA approved the first non-hormonal treatment, Brisdelle (paroxetine), to treat vasomotor symptoms associated with menopause.

Inquire Before buying the Report @ http://bit.ly/1mADxpR.

Covered in this Report

The Global Hormone Replacement Therapy market can be divided into three segments: Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, and Thyroid Hormone Replacement Therapy. This report covers the present scenario and the growth prospects of the Global Hormone Replacement Therapy market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the various hormone replacement therapies that are available in the market.

Global Hormone Replacement Therapy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC regions; it also covers the Global Hormone Replacement Therapy market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the main drivers in this market is the significant unmet need for HRT. The current treatment options are incapable of meeting the market requirements because of their lower safety profiles, leaving a large amount of unmet need in this market. The need for new treatment options with better safety results to address the current unmet need is huge.

Further, the report states that the Global HRT market faces some serious challenges. One of the main challenges is the high cost of HRT, which hinders its acceptance by patients. Many patients do not have the required budget to invest in high-cost treatment options. Adverse side effects of HRT are another major factor hampering the growth of the Global HRT market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Actavis plc
  • Bayer AG
  • Merck & Co. Inc.
  • Novartis AG
  • Novo Nordisk A/S

Other Prominent Vendors

  • Abbott Laboratories Ltd.
  • Amgen Inc.
  • ANI Pharmaceuticals Inc.
  • Hisamitsu Pharmaceutical Co. Inc.
  • Mylan Laboratories Inc.
  • Orion Corp.
  • QuatRx Pharmaceuticals Co.
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD Inc.

Key Market Driver

  • Significant Unmet Need for Hormone Replacement Therapy

Key Market Challenge

  • High Cost of Hormone Replacement Therapy

Key Market Trend

  • Paradigm Shift Toward Transdermal Systems

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?